Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brianna R Altman

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Addictive Behaviors|February 22, 2023
Induced negative affect's impact on self-reported cannabis use, expectancies, and problemsBrianna R Altman, Mitch Earleywine
Journal of American College Health : J of ACH|March 2, 2023
Undergraduate student perceptions of cognitive behavioral therapy, aerobic exercise, and their combination for depressionCody Gilbert, Mitch Earleywine, Brianna R Altman
Journal of Psychoactive Drugs|January 4, 2022
Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for DepressionBrianna R Altman, Mitch Earleywine, Joseph De Leo
Journal of Psychoactive Drugs|April 20, 2021
Cognitive Behavioral Therapy, Ketamine, and Combination Treatment for Depression: Impressions of Credibility in Participants with Self-Reported Depressive SymptomsMitch Earleywine, Brianna R Altman, Joseph De Leo
Substance Use & Misuse|November 4, 2020
Replicating the Dimensional Structure of Cannabis Problems: A Taxometric AnalysisMitch Earleywine, Thomas F Denson, Brianna R Altman
Journal of Psychoactive Drugs|July 20, 2019
Cannabis Expectancies for SleepBrianna R Altman, M N Mian, M Slavin, et al.
Journal of Psychopharmacology (Oxford, England)|December 5, 2023
Development of the Protective Strategies for Psychedelics Scale: A novel inventory to assess safety strategies in the context of psychedelicsMaha N Mian, Brianna R Altman, Fiona Low, et al.
Journal of Psychoactive Drugs|March 23, 2022
How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?Mitch Earleywine, Fiona Low, Brianna R Altman, et al.
Journal of Psychoactive Drugs|November 23, 2020
Confirming Savoring's Link to Fewer Cannabis ProblemsMaha N Mian, Brianna R Altman, Luna F Ueno, et al.
Cannabis (Albuquerque, N.M.)|June 8, 2023
Cannabis's Link to Schizotypy: Phenomenon, Measurement Bias, or Delusion?Brianna R Altman, Mitch Earleywine, Maha N Mian, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Addictive Behaviors|February 22, 2023
Induced negative affect's impact on self-reported cannabis use, expectancies, and problemsBrianna R Altman, Mitch Earleywine
Journal of American College Health : J of ACH|March 2, 2023
Undergraduate student perceptions of cognitive behavioral therapy, aerobic exercise, and their combination for depressionCody Gilbert, Mitch Earleywine, Brianna R Altman
Journal of Psychoactive Drugs|January 4, 2022
Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for DepressionBrianna R Altman, Mitch Earleywine, Joseph De Leo
Journal of Psychoactive Drugs|April 20, 2021
Cognitive Behavioral Therapy, Ketamine, and Combination Treatment for Depression: Impressions of Credibility in Participants with Self-Reported Depressive SymptomsMitch Earleywine, Brianna R Altman, Joseph De Leo
Substance Use & Misuse|November 4, 2020
Replicating the Dimensional Structure of Cannabis Problems: A Taxometric AnalysisMitch Earleywine, Thomas F Denson, Brianna R Altman
Journal of Psychoactive Drugs|July 20, 2019
Cannabis Expectancies for SleepBrianna R Altman, M N Mian, M Slavin, et al.
Journal of Psychopharmacology (Oxford, England)|December 5, 2023
Development of the Protective Strategies for Psychedelics Scale: A novel inventory to assess safety strategies in the context of psychedelicsMaha N Mian, Brianna R Altman, Fiona Low, et al.
Journal of Psychoactive Drugs|March 23, 2022
How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?Mitch Earleywine, Fiona Low, Brianna R Altman, et al.
Journal of Psychoactive Drugs|November 23, 2020
Confirming Savoring's Link to Fewer Cannabis ProblemsMaha N Mian, Brianna R Altman, Luna F Ueno, et al.
Cannabis (Albuquerque, N.M.)|June 8, 2023
Cannabis's Link to Schizotypy: Phenomenon, Measurement Bias, or Delusion?Brianna R Altman, Mitch Earleywine, Maha N Mian, et al.
Pageof 3